Trade Names:
Status: Approved
Entry Type: Small molecule
Molecule Category: Salt
Parent Compound: CAFFEINE

Indications

Mesh Heading Maximum Phase Reference
Apnea Phase 3 ClinicalTrials
Liver Diseases Phase 1 ClinicalTrials
Bronchopulmonary Dysplasia Phase 4 ClinicalTrials
Pain, Postoperative Early Phase 1 ClinicalTrials
Apnea Phase 2 ClinicalTrials
Retinopathy of Prematurity Phase 2 ClinicalTrials
Premature Birth Phase 3 ClinicalTrials
Ileus Phase 2 ClinicalTrials
Brain Injuries; Hemorrhage Phase 4 ClinicalTrials
Apnea; Premature Birth Phase 3 ClinicalTrials

Related Entries

Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Injury, poisoning and procedural complications
17.09
Cardiac disorders
14.57
Psychiatric disorders
9.05
Nervous system disorders
8.54
Metabolism and nutrition disorders
7.54
Vascular disorders
7.54
Gastrointestinal disorders
6.53
General disorders and administration site conditions
5.53
Investigations
5.53
Respiratory, thoracic and mediastinal disorders
4.02
Musculoskeletal and connective tissue disorders
3.52
Endocrine disorders
3.02
Skin and subcutaneous tissue disorders
3.02